Ivan Civettini

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations.

Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations.

Journal: Bioinformatics (Oxford, England)

Published: August 24, 2026

Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution.

Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution.

Journal: NEJM evidence

Published: May 26, 2026

Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study.

Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: results from a multicenter cooperative study.

Journal: Annals of hematology

Published: July 23, 2025

Expression of Human Endogenous Retrovirus Env Gene Product Is a Hallmark of Sidedness in Operable Colorectal Cancer.

Expression of Human Endogenous Retrovirus Env Gene Product Is a Hallmark of Sidedness in Operable Colorectal Cancer.

Journal: Oncology

Published: October 31, 2024

Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies.

Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies.

Journal: Biomedicines

Published: September 22, 2024

Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype.

Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype.

Journal: Med (New York, N.Y.)

Published: December 02, 2023

BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis.

BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis.

Journal: American journal of hematology

Published: November 25, 2023

Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.

Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients.

Journal: Blood transfusion = Trasfusione del sangue

Published: September 29, 2023

Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making.

Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making.

Journal: British journal of haematology

Published: August 29, 2023

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis.

Journal: Blood

Published: June 20, 2023

DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients.

DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients.

Journal: HemaSphere

Published: October 31, 2022

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia.

Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia.

Journal: European journal of haematology

Published: October 03, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026